Eric Williams joined Rebus Biosystems as Chief Financial Officer in 2022. He brings over 30 years of cross-functional experience in high tech businesses from start-ups to large scale public companies. Prior to joining Rebus Biosystems, Eric has served as CFO in a variety of high-tech companies including NovalSignal, Evidation Health, Mimosa and Soraa. In addition, Eric spent several years early in his career in data sciences, thermal modeling and analysis, test and product marketing followed by several years in corporate development (M&A and corporate venture capital). Eric graduated from the University of CA, Irvine with a BS in Engineering and the University of San Diego, with an MBA in International Business.